Share-based Payment Arrangement, Expense in USD of BIORA THERAPEUTICS, INC. from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BIORA THERAPEUTICS, INC. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q2 2019 to Q3 2024.
  • BIORA THERAPEUTICS, INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2024 was $1.28M, a 87.8% decline year-over-year.
  • BIORA THERAPEUTICS, INC. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2024 was $5.94M, a 64.8% decline year-over-year.
  • BIORA THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2023 was $16.5M, a 111% increase from 2022.
  • BIORA THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2022 was $7.8M, a 42.4% decline from 2021.
  • BIORA THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2021 was $13.6M, a 27.1% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

BIORA THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $5.94M $1.28M -$9.25M -87.8% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 $15.2M $1.57M -$441K -21.9% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2024
Q1 2024 $15.6M $1.54M -$845K -35.4% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $16.5M $1.55M -$375K -19.5% 01 Oct 2023 31 Dec 2023 10-K 01 Apr 2024
Q3 2023 $16.9M $10.5M +$8.15M +342% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 $8.7M $2.01M +$568K +39.3% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024
Q1 2023 $8.14M $2.38M +$331K +16.1% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $7.8M $1.92M -$663K -25.7% 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024
Q3 2022 $8.47M $2.38M -$1.49M -38.4% 01 Jul 2022 30 Sep 2022 10-Q 15 May 2024
Q2 2022 $9.96M $1.45M -$3.02M -67.7% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $13M $2.05M -$577K -21.9% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 $13.6M $2.58M +$371K +16.8% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 $13.2M $3.87M +$498K +14.8% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 $12.7M $4.47M +$1.45M +47.8% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 $11.2M $2.63M +$573K +27.9% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q4 2020 $10.7M $2.21M +$1.31M +146% 01 Oct 2020 31 Dec 2020 10-K 28 Mar 2022
Q3 2020 $9.36M $3.37M +$2.74M +435% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $6.61M $3.02M +$2.43M +407% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 $4.19M $2.06M 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 $900K 01 Jan 2020 31 Jan 2020 10-K 28 Mar 2022
Q3 2019 $631K 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 $597K 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020

BIORA THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $16.5M +$8.67M +111% 01 Jan 2023 31 Dec 2023 10-K 01 Apr 2024
2022 $7.8M -$5.75M -42.4% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024
2021 $13.6M +$2.89M +27.1% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 $10.7M +$8.29M +349% 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2022
2019 $2.38M 01 Jan 2019 31 Dec 2019 10-K 18 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.